Oncology

Improving Goals of Care Conversations Between Doctors and Young Adults With Cancer
Conditions: Cancer

Interventions: Other: Jumpstart GOCC intervention

Sponsors: Memorial Sloan Kettering Cancer Center

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 3, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
SBRT for Ultra-Central NonSmall Cell Lung Cancer
Conditions: Nonsmall Cell Lung Cancer Stage

Interventions: Radiation: SBRT

Sponsors: Georgetown University; Accuray Incorporated

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 2, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)
Conditions: Carcinoma, Hepatocellular

Interventions: Drug: Lenvatinib

Sponsors: Eisai Inc.

Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 1, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Roginolisib Plus Obinutuzumab + Venetoclax in R/R CLL
Conditions: Chronic Lymphocytic Leukemia (CLL); Refractory Chronic Lymphocytic Leukemia

Interventions: Drug: Roginolisib; Drug: Obinutuzumab; Drug: Venetoclax

Sponsors: Dana-Farber Cancer Institute; iOnctura

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 30, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision
Conditions: Surgical Site Infection; Skin Cancer; Wound Healing

Interventions: Device: Cyanoacrylate Skin Adhesive; Procedure: Fast Gut Running Epidermal Suture Closure; Procedure: Vicryl Rapide Running Epidermal Suture Closure; Procedure: Prolene Running Epidermal Suture Closure

Sponsors: University of Minnesota

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 29, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery
Conditions: Postoperative Pain; Acute Pain; Skin Cancer; Cutaneous Malignancy; Mohs Surgery

Interventions: Drug: Suzetrigine; Drug: Acetaminophen Plus Ibuprofen

Sponsors: University of Minnesota; Minnesota Cancer Clinical Trials Network

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 28, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms
Conditions: Neuroendocrine Neoplasm; Gastroenteropancreatic Neuroendocrine Neoplasm

Interventions: Drug: Somatostatin Analogue(s)

Sponsors: Washington University School of Medicine; Curium US LLC

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 27, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients
Conditions: Metastatic Breast Cancer; Metastatic Breast Cancer (MBC); Metastatic Breastcancer

Interventions: Behavioral: Core Intervention; Behavioral: EHR Integration (On v. Off); Behavioral: Weekly Coaching; Behavioral: Social+ (on v. off); Behavioral: Static Goal Setting; Behavioral: Bi-Weekly Coaching; Behavioral: Highly Tailored Goal Setting

Sponsors: Northwestern University; National Cancer Institute (NCI)

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 26, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Personalizing Veterans’ Lung Cancer Screening and Diagnosis
Conditions: Lung Cancer Screening; Military Service-related Environmental and Occupational Exposures; Cancer Survivor; Family History of Lung Cancer; COPD; Burn Pit Exposure; Agent Orange Exposure; Radiation Exposure; Asbestos Exposure; Lung Neoplasm

Interventions: Procedure: Low-dose computed tomography

Sponsors: VA Office of Research and Development; Bristol-Myers Squibb; Vanderbilt-Ingram Cancer Center

Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 25, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Patients With Clinically Significant Immune Related Adverse Events
Conditions: Any Advanced Solid Tumors

Interventions: Drug: Sarilumab; Drug: ICI Therapy

Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Sanofi-Regeneron; Bristol-Myers Squibb

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 24, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine